BBP
Virtus Biotech ETFstockNYSEETF
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing. The fund is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 103.75 | 2026-11-10 | -4.92% | 1.198 |
| 1M | 100.20 | 2026-10-16 | -1.55% | 1.124 |
| 3M | 102.73 | 2026-08-17 | -3.97% | 1.152 |
| 6M | 84.35 | 2026-05-18 | +16.95% | 0.762 |
| 1Y | 77.49 | 2025-11-17 | +27.30% | 0.922 |
| 2Y | 60.53 | 2024-11-18 | +62.96% | — |
| 5Y | 50.03 | 2021-11-17 | +97.17% | 0.853 |
Virtus Biotech ETF (NYSE:BBP) stock price today is $98.65, and today's volume is 10,077. BBP is down 0.655% today. The 30 day average volume is 12,079. BBP market cap is $128.24M with 1.30M shares outstanding.